![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euroapi-corp-ad-w30-desktop-header-1-2gif-57087.gif)
![Euroapi Company Header](https://www.pharmacompass.com/image/flap/euro-api-mob-header-w30gif-19381.gif)
API Suppliers
0
US DMFs Filed
0
CEP/COS Certifications
0
JDMFs Filed
0
EU WC
0
Listed Suppliers
0
0
0
USA (Orange Book)
0
Europe
0
Canada
0
Australia
0
South Africa
0
Uploaded Dossiers
0
U.S. Medicaid
0
Annual Reports
0
0
USFDA Orange Book Patents
0
USFDA Exclusivities
0
Blog #PharmaFlow
0
News
EDQM
0
USP
0
JP
0
Other Listed Suppliers
0
0
https://www.financialexpress.com/budget/budget-2024-pharma-sector-demands-substantial-rampd-incentives-tax-relief-and-strong-ip-framework-3543082/
https://www.indianpharmapost.com/news/orchid-pharma-and-cipla-collaborate-to-launch-antibiotic-cefepime-enmetazobactam-in-india-15819
https://www.biospectrumindia.com/news/73/24731/orchid-pharma-receives-dcgi-approval-for-cefepime-and-enmetazobactam-antibiotic.html
https://www.pharmaceutical-technology.com/news/uk-mhra-advanz-pharma-antibiotic/